Immunio, a Montreal, Canada-based runtime application software protection (RASP) platform, raised $5m in Series A funding.
The round, which brought total funds raised to date to $8.3M, was led by White Star Capital, with participation from previous seed investors.
The company intends to usen the funds to accelerate growth.
Led by Zaid Al Hamami, CEO and Cofounder, and newly added Goran Begic (vice president of product) and Richard April (chief marketing officer), Immunio provides a real-time web application security (RASP) platform that allows companies to release software into production efficiently, knowing that their applications will be “immune” to exploitation, this reducing risk and giving security teams the information and time to address vulnerabilities.
Inserted into the application itself, RASP can flag vulnerabilities within the app and immediately block attacks in real time, allowing both developers and IT operations teams to understand where the vulnerability was, how it was blocked and what the steps are to fix it.
Immunio is generally available and accessible through a free trial version at www.immun.io.